AiCuris Anti-infective Cures

Biopharmaceutical company (now part of Asahi Kasei)

Appears in 1 story

Stories

FDA approves first new herpes drug mechanism in nearly 30 years

New Capabilities

Developer of pritelivir, absorbed by Asahi Kasei

The Food and Drug Administration approved Hovilpri (pritelivir) on October 9 for persistent herpes sores in adults with weakened immune systems. It is the first herpes treatment with a new mechanism of action in nearly 30 years.

Updated 1 hour ago